GSK-49653/137



A Study to Evaluate the Efficacy of Rosiglitazone (BRL-049653) on Reduction of Microalbuminuria in Subjects with Type 2 Diabetes Mellitus
rosiglitazone
49653/137
NCT00500955
Diabetes Mellitus, Type 2
Phase 3
 
An analysis-ready dataset is not available for this study. An annotated case report form is not available for this study. A blank case report form will be provided.
September 2013